No Data
No Data
Cognition Therapeutics Supports Lewy Body Dementia Awareness Month and the Need for Improved Treatments for the Second Most Common Dementia
Cognition Therapeutics Highlights CT1812 Potential in CNS Disorders
12 Health Care Stocks Moving In Monday's After-Market Session
Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences
Express News | Cognition Therapeutics Shares Are Trading Higher After the Company Announced Results From Its SEQUEL Study of CT1812 for Alzheimer's Disease
Cognition Therapeutics Reports Positive Results for Alzheimer's Drug in Study
No Data
No Data